Skip to main content

Clinical trial IJB-MULTI-MIME-A-2017

IJB-MULTI-MIME-A-2017 Multiorgan Metabolic imaging response assessment of Abemaciclib: the MiMe-A trial

Cancers
Organ Multiple
Trial status Trial closed
Investigator
Trial type
Interventional with experimental drug
Phase Trial phase 2
Academic trial Oui
Sponsor Institut Jules Bordet
EudraCT Identifier 2017-000123-28
ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03339843
Inclusion criteria Metastatic or non-resecable. Refractory to platinum regimen
Last update